Skip to main content

Advertisement

SpringerLink
Log in

Urinary-derived human chorionic gonadotropin to induce tolerance and promote healing in steroid-refractory GvHD

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Elmaagacli AH, Ditschkowski M, Steckel NK, Gromke T, Ottinger H, Hillen U et al. Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD. Bone Marrow Transplant 2014; 49: 800–805.

    Article  CAS  Google Scholar 

  2. Schumacher A, Heinze K, Witte J, Poloski E, Linzke N, Woidacki K et al. Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance. J Immunol 2013; 190: 2650–2658.

    Article  CAS  Google Scholar 

  3. Yarram SJ, Jenkins J, Cole LA, Brown NL, Sandy JR, Mansell JP . Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations. Fertil Steril 2004; 82: 232–233.

    Article  CAS  Google Scholar 

  4. Holtan SG, Verneris MR, Schultz KR, Newell LF, Meyers G, He F et al. Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802. Biol Blood Marrow Transplant 2015; 21: 1029–1036.

    Article  CAS  Google Scholar 

  5. Holtan SG, Chen Y, Kaimal R, Creedon DJ, Enninga EA, Nevala WK et al. Growth modeling of the maternal cytokine milieu throughout normal pregnancy: macrophage-derived chemokine decreases as inflammation/counterregulation increases. J Immunol Res 2015; 2015: 952571.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported in part by the UMN Cytokine Reference Laboratory (AP-M), and the Masonic Cancer Center, University of Minnesota (SGH). We thank Michael Ehrhardt for expert technical assistance.

Author information

Authors and Affiliations

  1. Department of Medicine, Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA

    S G Holtan

  2. Department of Pediatrics, Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA

    A Panoskaltsis-Mortari

Authors
  1. S G Holtan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Panoskaltsis-Mortari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S G Holtan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Holtan, S., Panoskaltsis-Mortari, A. Urinary-derived human chorionic gonadotropin to induce tolerance and promote healing in steroid-refractory GvHD. Bone Marrow Transplant 51, 142–143 (2016). https://doi.org/10.1038/bmt.2015.220

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.220

  • Springer Nature Limited

This article is cited by

Search

Navigation